Ethics and governance of biomedical research : theory and practice
著者
書誌事項
Ethics and governance of biomedical research : theory and practice
(Research ethics forum, v. 4)
Springer, c2016
- : hbk
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references
内容説明・目次
内容説明
In this book,
scholars with different disciplinary and national backgrounds argue for
possible answers and analyse case studies on current issues of governance in
biomedical research. These issues comprise among others the research-care
distinction, risk evaluation in early human trials, handling of incidental
findings, nocebo effects, cluster randomized trials, publication bias, or
consent in biobank research. This book demonstrates how new technologies and
research possibilities multiply or intensify already known governance
challenges, leaving room for ethical analysis and complex moral choices.
Clinical researchers, research ethics committee members and research ethicists
have all to deal with such challenges on a daily basis. While general
reflection on core concepts of research ethics is seldom pointless, those
confronted with hard moral choices do need more practical and contextualized
reflection on the said issues. This book particularly provides such
contextualized reflections and aims to inform all those who study, conduct,
regulate, fund, or participate in biomedical research.
目次
- Introducing new domains of research governance
- Govind C. Persad, JD, BS, BA.- Should Research Ethics Encourage the Production of Cost-Effect Interventions?
- Rebecca Johnson, MA.- From altruists to Workers: What Claims Should Healthy Participants in Phase I Trials Have Against Trial Employers?
- Luana Colloca, PhD.- Nocebo effect: The dilemma of disclosing adverse events
- Jan-Ole Reichardt, MA.- Encouraging conscientiousness in risk associated areas of medical research Challenges in common domains of research governance
- Sara Anna Suzan Dekking, MAE et al.- Discriminating between Research and Care in Paediatric Oncology. Ethical Appraisal of the ALL- 10 and 11 protocols of the Dutch Childhood Oncology Group (DCOG)
- Imme Petersen, PhD et al.- What Does the Child's Assent to Research Participation Mean to Parents? Empirical Findings in Paediatric Oncology in Germany
- Marcin Waligora, PhD.- Assent in paediatric research and its consequences
- Rosemarie Bernabe, PhD.- Ethical Issues in Postauthorization Drug Trials
- Anette Blumle, PhD et al.- Fate of Clinical Research Studies after Ethical Approval - Follow-Up of Study Protocols until Publication
- Daniel Strech, MD, PhD.- et al. Do editorial policies support ethical research? A thematic text analysis of author instructions in psychiatry journals Improving common domains of research governance
- Jonathan Kimmelman, PhD.- Risk/Benefit Assessment in Launching Early Human Trials
- Annette Rid, MD.- Guidelines for Biomedical Research Involving Human Subjects Setting Thresholds of Acceptable Research Risk: Lessons from the Debate about Minimal Risk
- Sapfo Lignou, MSc, MA et al.- Towards an Alternative Account for Defining Acceptable Risk in Non-beneficial Pediatric Research
- Roger Brownsword, PhD.- Big biobanks: Three Major Governance Challenges and Some Mini-Constitutional Responses
- Bettina Schmietow, MA.- Dynamic Consent to Biobank Research - Paradigm Shift or Red Herring?.
「Nielsen BookData」 より